Serum KL-6 can distinguish between different phenotypes of severe COVID-19
J Med Virol
.
2021 Jan;93(1):158-160.
doi: 10.1002/jmv.26268.
Epub 2020 Jul 19.
Authors
Hideta Nakamura
1
,
Kazuya Miyagi
1
,
Mariko Otsuki
1
,
Yuri Higure
1
,
Naoya Nishiyama
1
,
Takeshi Kinjo
1
,
Masashi Nakamatsu
1
,
Shusaku Haranaga
1
,
Masao Tateyama
1
,
Jiro Fujita
1
Affiliation
1
Department of Infectious, Respiratory, and Digestive Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan.
PMID:
32633842
PMCID:
PMC7361808
DOI:
10.1002/jmv.26268
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
COVID-19*
Humans
Phenotype
ROC Curve
SARS-CoV-2
Substances
Biomarkers